Matthew Grunseth

Matthew Grunseth is a Senior Director of Transactions at AstraZeneca, focusing on oncology business development and licensing. They have held various positions at AstraZeneca since 2021, advancing from Associate Director to Senior Director. Prior experience includes roles at AbbVie as a Senior Manager and Associate Director in technology licensing, as well as a Graduate Consultant position at Dow AgroSciences. They also completed an MBA internship at Los Alamos National Laboratory and served in multiple roles at City of Hope in technology licensing.